Genocea Biosciences Inc (GNCAQ)

[ash111]

GNCA Recent analyst ratings and price targets($13 to $40):

04/01/2016 – Genocea Biosciences Inc had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 13 price target on the stock.

03/31/2016 – Genocea Biosciences Inc had its “buy” rating reiterated by analysts at Needham & Company. They now have a USD 15 price target on the stock.

03/31/2016 – Genocea Biosciences Inc had its “outperform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 17 price target on the stock.

12/17/2015 – UBS began new coverage on Genocea Biosciences Inc giving the company a “buy” rating. They now have a USD 15 price target on the stock.

10/19/2015 – Genocea Biosciences Inc had its “buy” rating reiterated by analysts at Piper Jaffray.

10/07/2015 – Genocea Biosciences Inc had its “outperform” rating reiterated by analysts at Cowen. They now have a USD 40 price target on the stock.

03/03/2014 – Citigroup began new coverage on Genocea Biosciences Inc giving the company a “buy” rating.

http://www.sharetrading.news/2016/05/22/next-weeks-broker-price-targets-for-genocea-biosciences-inc-gnca-4/